[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.90.95. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 538
Citations 0
Editorial
May 2015

Cerebrospinal Fluid Vascular Endothelial Growth Factor

Author Affiliations
  • 1Sanders-Brown Center on Aging, Division of Neuropathology, Department of Pathology, University of Kentucky, Lexington
JAMA Neurol. 2015;72(5):502-503. doi:10.1001/jamaneurol.2015.34

In this issue of JAMA Neurology, Hohman et al1 provide new insights into a biomarker related to cognitive performance in advanced age. They report that elevated levels of vascular endothelial growth factor (VEGF) in cerebrospinal fluid (CSF) are associated with improved hippocampal volume, episodic memory, and executive function. Moreover, statistical analyses were applied to test how the CSF levels of β-amyloid 42 and tau may interact with CSF VEGF levels to help predict neurocognitive factors in their sampled research participants. Hohman and colleagues report on analyses from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database, which comprises neuroimaging, CSF, and neurocognitive longitudinal data on 279 patients, regrettably without corresponding autopsy data.

First Page Preview View Large
First page PDF preview
First page PDF preview
×